US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics

科研成果: 期刊稿件文章同行评审

源语言英语
页(从-至)151-156
页数6
期刊BMJ Evidence-Based Medicine
28
3
DOI
出版状态已出版 - 6月 1 2023

!!!ASJC Scopus Subject Areas

  • 一般医学

指纹

探究 'US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics' 的科研主题。它们共同构成独一无二的指纹。

引用此